CD40LG and acute lymphoblastic leukemia: Our findings showed that in patients with ALL and lymphoma, the number of individuals who had anti- Toxoplasma IgG antibodies, before and after treatment, was 46.9%, and pre and post-treatment positive IgM cases were also observed.